CMS has announced a new plan to “modernize” Medicare and find new ways to “protect taxpayers from fraud, waste and abuse.” Could AI technologies play key role in the agency’s strategy?

The rise of AI is an exciting change for healthcare providers all over the world, but implementing these groundbreaking technologies still comes with its fair share of significant challenges.  

Medical imaging professionals and radiation experts are in a position to play a significant role as AI technologies continue to evolve, according to a new commentary published in the Journal of Medical Imaging and Radiation Sciences.

The Bipartisan Policy Center (BPC) hosted an open discussion on the future of AI on Wednesday, Oct. 16, in Washington, D.C. Topics included AI’s impact on the economy and how public policies may change in the near future as a response to these evolving technologies.

Former Google China President Kai-Fu Lee believes the rise of AI “will come in waves,” he told FOX Business. Lee said healthcare is one of the industries that will benefit the most from AI. 

The FDA has issued a voluntary recall of valsartan, due to concerns of an impurity N-nitrosodimethylamine (NDMA), a known carcinogen, which was found in a batch of the drug manufactured in China. Valsartan is commonly used to control hypertension and heart failure.

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ban on dual-use technology with the aim of regulating mental privacy and integrity of humans. Findings were published in Neuron.

As cyberattack become increasingly common incidents, healthcare professionals must push security to the forefront. In a presentation given at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Jim Whitfill, CMO of innovation Health Partners and president of Lumetis, described the current cybersecurity environment and detailed how professionals can take steps toward improving privacy.